Supriya Lifescience is betting big on capacity expansion to double revenue over the next two years, as the Mumbai-based active pharmaceutical ingredient (API) maker leans on niche products and ...
It’s honestly getting harder to separate AI-powered pharma companies from pharma-focused AI companies as AI becomes more and more embedded in biopharma operations. We included BenevolentAI in our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback